Saller Maximilian M, Huettl Rosa-Eva, Mayer Julius M, Feuchtinger Annette, Krug Christian, Holzbach Thomas, Volkmer Elias
Experimental Surgery and Regenerative Medicine (ExperiMed), Department of General, Trauma and Reconstructive Surgery, Ludwig-Maximilians-University (LMU), Munich, Germany.
Max-Planck-Institute of Psychiatry, Department of Stress Neurobiology and Neurogenetics, Munich, Germany.
Neural Regen Res. 2018 May;13(5):854-861. doi: 10.4103/1673-5374.232481.
Despite the regenerative capabilities of peripheral nerves, severe injuries or neuronal trauma of critical size impose immense hurdles for proper restoration of neuro-muscular circuitry. Autologous nerve grafts improve re-establishment of connectivity, but also comprise substantial donor site morbidity. We developed a rat model which allows the testing of different cell applications, i.e., mesenchymal stem cells, to improve nerve regeneration in vivo. To mimic inaccurate alignment of autologous nerve grafts with the injured nerve, a 20 mm portion of the sciatic nerve was excised, and sutured back in place in reversed direction. To validate the feasibility of our novel model, a fibrin gel conduit containing autologous undifferentiated adipose-derived stem cells was applied around the coaptation sites and compared to autologous nerve grafts. After evaluating sciatic nerve function for 16 weeks postoperatively, animals were sacrificed, and gastrocnemius muscle weight was determined along with morphological parameters (g-ratio, axon density & diameter) of regenerating axons. Interestingly, the addition of undifferentiated adipose-derived stem cells resulted in a significantly improved re-myelination, axon ingrowth and functional outcome, when compared to animals without a cell seeded conduit. The presented model thus displays several intriguing features: it imitates a certain mismatch in size, distribution and orientation of axons within the nerve coaptation site. The fibrin conduit itself allows for an easy application of cells and, as a true critical-size defect model, any observed improvement relates directly to the performed intervention. Since fibrin and adipose-derived stem cells have been approved for human applications, the technique can theoretically be performed on humans. Thus, we suggest that the model is a powerful tool to investigate cell mediated assistance of peripheral nerve regeneration.
尽管周围神经具有再生能力,但严重损伤或临界尺寸的神经元创伤给神经肌肉回路的正常恢复带来了巨大障碍。自体神经移植可改善神经连接的重建,但也会导致供体部位出现明显的并发症。我们开发了一种大鼠模型,可用于测试不同的细胞应用,即间充质干细胞,以改善体内神经再生。为模拟自体神经移植与受损神经的不准确对齐,切除了20毫米的坐骨神经部分,并将其反向缝合回原位。为验证我们新模型的可行性,将含有自体未分化脂肪来源干细胞的纤维蛋白凝胶导管应用于吻合部位周围,并与自体神经移植进行比较。术后评估坐骨神经功能16周后,处死动物,测定腓肠肌重量以及再生轴突的形态学参数(g比值、轴突密度和直径)。有趣的是,与未植入细胞的导管的动物相比,添加未分化脂肪来源干细胞可显著改善髓鞘再生、轴突长入和功能结果。因此,所提出的模型具有几个有趣的特点:它模拟了神经吻合部位轴突在大小、分布和方向上的某种不匹配。纤维蛋白导管本身便于细胞的应用,并且作为一个真正的临界尺寸缺损模型,任何观察到的改善都直接与所进行的干预措施相关。由于纤维蛋白和脂肪来源干细胞已被批准用于人类应用,从理论上讲,该技术可以在人类身上进行。因此,我们认为该模型是研究细胞介导的周围神经再生辅助作用的有力工具。